1. Home
  2. CR vs BIO Comparison

CR vs BIO Comparison

Compare CR & BIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Crane Company

CR

Crane Company

HOLD

Current Price

$188.41

Market Cap

10.5B

Sector

Industrials

ML Signal

HOLD

Logo Bio-Rad Laboratories Inc.

BIO

Bio-Rad Laboratories Inc.

HOLD

Current Price

$302.70

Market Cap

8.2B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CR
BIO
Founded
1855
1952
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Laboratory Analytical Instruments
Sector
Industrials
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.5B
8.2B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
CR
BIO
Price
$188.41
$302.70
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$223.20
$358.50
AVG Volume (30 Days)
305.9K
158.3K
Earning Date
01-26-2026
02-12-2026
Dividend Yield
0.49%
N/A
EPS Growth
37.96
N/A
EPS
6.25
N/A
Revenue
$2,268,100,000.00
$2,557,500,000.00
Revenue This Year
$10.78
$1.62
Revenue Next Year
$13.09
$2.26
P/E Ratio
$34.42
N/A
Revenue Growth
19.64
N/A
52 Week Low
$127.04
$211.43
52 Week High
$203.89
$373.69

Technical Indicators

Market Signals
Indicator
CR
BIO
Relative Strength Index (RSI) 53.24 42.26
Support Level $182.87 $295.01
Resistance Level $194.17 $307.07
Average True Range (ATR) 3.61 8.09
MACD 0.05 -1.25
Stochastic Oscillator 47.79 22.23

Price Performance

Historical Comparison
CR
BIO

About CR Crane Company

Crane is a diversified industrial firm that manufactures a broad range of products, including valves, pumps, aerospace components, and fiberglass-reinforced plastic panels. Its business is organized into two segments: aerospace and electronics, and process flow technologies. Crane generated approximately $2.1 billion in revenue in 2024.

About BIO Bio-Rad Laboratories Inc.

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

Share on Social Networks: